Cobicistat + Darunavir + Emtricitabine + Tenofovir Alafenamide

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Brands with this exact combination

BrandDoseManufacturer
Darunavir 800mg / Cobicistat 150mg / Emtricitabine 200mg / Tenofovir alafenamide 10mg tabletsAUESGB800 mg / 150 mg / 200 mg / 10 mgJanssen-Cilag International N.V
darunavir + cobicistat + emtricitabina + tenofovir alafenamidaES800 mg / 150 mg / 200 mg / 10 mgJanssen-Cilag International N.V
Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamideUS800 mg / 150 mg / 200 mg / 10 mgJanssen Products LP
cobicistat + emtricitabine + darunavir + tenofovir alafenamideAU——
信澤力膜衣錠TW—嬌生股份有限公司
SYMTUZA 800/150/200/10 darunavir/cobicistat/emtricitabine/tenofovir alafenamide 800/150/200/10 mg film-coated tabletsAU10 mg / 800 mg / 150 mg / 200 mgJanssen-Cilag Pty Ltd

Same combination in other markets

These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.